Literature DB >> 9249111

Ocular surface disorders in the critically ill.

H Imanaka1, N Taenaka, J Nakamura, K Aoyama, H Hosotani.   

Abstract

Abnormalities of the cornea and conjunctiva occur in association with neurological diseases, nocturnal lagophthalmos, coma, infection, and mechanical ventilation. We investigated the incidence and causes of ocular surface disorders in critically ill patients. In a retrospective study, the presence of conjunctivitis and corneal erosion was determined by reviewing the medical charts of 143 mechanically ventilated patients (intensive care unit [ICU] stay > or =7 days). In the subsequent prospective study, 15 patients who had sedatives or muscle relaxants administered continuously for more than 48 h in the ICU were investigated. Corneal erosion was examined using a slit lamp once a day. Ocular surface disorder was found in 28 of the 143 patients (20%) whose ICU stay exceeded 7 days. The incidence increased with continuous sedation (35% vs 15%). The incidence also increased with continuous neuromuscular blockade (39% vs 11%). In the prospective study, nine patients (60%) developed corneal erosion. A patient's inability to fully close his or her eyes increased the incidence (P < 0.01) of corneal erosion. Protective eyelid taping was effective in preventing and treating the corneal erosion. In conclusion, the critically ill often develop ocular surface disorders, especially when sedated and immobilized. A close relationship was observed between these conditions and the inability to close one's eyes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249111     DOI: 10.1097/00000539-199708000-00018

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  9 in total

1.  Supportive care of a critically ill child.

Authors:  Sunil Saharan; Rakesh Lodha; Sushil K Kabra
Journal:  Indian J Pediatr       Date:  2010-12-31       Impact factor: 1.967

2.  Prevention of exposure keratopathy in intensive care unit.

Authors:  Hua Shan; Du Min
Journal:  Int J Ophthalmol       Date:  2010-12-18       Impact factor: 1.779

3.  Evaluation of eye care and ocular findings in critically ill COVID-19 patients.

Authors:  Zarife Ekici Gok; Abdullah Gok; Leman Acun Delen; Umut S Kasapoglu; Esra Gurbuz; Kayhan Mutlu
Journal:  Int J Clin Pract       Date:  2021-10-03       Impact factor: 3.149

4.  A randomised controlled study of the efficacy of hypromellose and Lacri-Lube combination versus polyethylene/Cling wrap to prevent corneal epithelial breakdown in the semiconscious intensive care patient.

Authors:  Natasha Koroloff; Robert Boots; Jeff Lipman; Peter Thomas; Claire Rickard; Fiona Coyer
Journal:  Intensive Care Med       Date:  2004-03-10       Impact factor: 17.440

5.  Protocolized eye care prevents corneal complications in ventilated patients in a medical intensive care unit.

Authors:  Mohammad Feroz Azfar; Muhammad Faisal Khan; Abdulaziz H Alzeer
Journal:  Saudi J Anaesth       Date:  2013-01

6.  Ocular surface disorders in intensive care unit patients.

Authors:  Tuba Berra Saritas; Banu Bozkurt; Baris Simsek; Zeynep Cakmak; Mehmet Ozdemir; Alper Yosunkaya
Journal:  ScientificWorldJournal       Date:  2013-10-29

7.  Prediction of risk and incidence of dry eye in critical patients.

Authors:  Diego Dias de Araújo; Natália Gherardi Almeida; Priscila Marinho Aleixo Silva; Nayara Souza Ribeiro; Andreza Werli-Alvarenga; Tânia Couto Machado Chianca
Journal:  Rev Lat Am Enfermagem       Date:  2016-05-17

8.  Incidence, risk factors and impact of protocolised care on exposure keratopathy in critically ill adults: a two-phase prospective cohort study.

Authors:  Obaid Kousha; Zubaid Kousha; Jonathan Paddle
Journal:  Crit Care       Date:  2018-01-16       Impact factor: 9.097

9.  Descemetocele and bilateral, severe Pseudomonas keratitis in an intensive care unit patient with Graves' orbitopathy: A case report.

Authors:  Yun Chen Hsieh; Chun-Chen Chen
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.